Testosterone Administration Alters Hepatic Blood Flow Across Age: Systematic Review of Animal Experimental Studies

Ricardo Aparecido Baptista Nucci; Valéria Simões Tanasov; Walter Krause Neto; Romeu Rodrigues de Souza; Eliane Florencio Gama

doi:10.1055/s-0038-1669470

Journal of Morphological Sciences, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · Journal of Morphological Sciences 2018; 35(02): 096-101
DOI: 10.1055/s-0038-1669470

Review Article

Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Testosterone Administration Alters Hepatic Blood Flow Across Age: Systematic Review of Animal Experimental Studies

Autor*innen

Ricardo Aparecido Baptista Nucci

¹Aging Studies Program (MS), Universidade São Judas Tadeu, São Paulo, SP, Brazil

²Laboratory of Morphoquantitative Studies and Immunohistochemistry, Department of Aging Sciences, Universidade São Judas Tadeu, São Paulo, SP, Brazil
Valéria Simões Tanasov

²Laboratory of Morphoquantitative Studies and Immunohistochemistry, Department of Aging Sciences, Universidade São Judas Tadeu, São Paulo, SP, Brazil
Walter Krause Neto

³Laboratory of Morphoquantitative Studies and Immunohistochemistry, Department of Physical Education, Universidade São Judas Tadeu, São Paulo, SP, Brazil
Romeu Rodrigues de Souza

²Laboratory of Morphoquantitative Studies and Immunohistochemistry, Department of Aging Sciences, Universidade São Judas Tadeu, São Paulo, SP, Brazil

³Laboratory of Morphoquantitative Studies and Immunohistochemistry, Department of Physical Education, Universidade São Judas Tadeu, São Paulo, SP, Brazil
Eliane Florencio Gama

¹Aging Studies Program (MS), Universidade São Judas Tadeu, São Paulo, SP, Brazil

²Laboratory of Morphoquantitative Studies and Immunohistochemistry, Department of Aging Sciences, Universidade São Judas Tadeu, São Paulo, SP, Brazil

³Laboratory of Morphoquantitative Studies and Immunohistochemistry, Department of Physical Education, Universidade São Judas Tadeu, São Paulo, SP, Brazil

Abstract

Testosterone levels decline gradually with advancing age. At this point, testosterone administration as a therapy has been largely used to improve different outcomes. However, testosterone induces dose-dependent negative effects on the structure and function of the liver across age. Therefore, the present study aimed to carry out a systematic review of the effects of testosterone administration on the hepatic structure of adult and aged animals. We have searched the PubMed, Google Scholar, Science Direct, Scielo and Lilacs databases for animal experimental studies on the effects of testosterone administration on the hepatic structure across age. After applying the inclusion and exclusion criteria, we included two articles in a systematic review and meta-analysis (regarding adult/aged rats). We have shown through a systematic review with meta-analysis that testosterone may cause chronic hepatic congestion. However, the present review had a small number of studies, which was considered a limitation. At this point, we encourage the development of more studies to elucidate the cellular and molecular mechanisms involved in hepatic injuries, as well as the hepatic metabolism of exogenous testosterone across age.

Keywords

aging - liver - hepatic structure - testosterone - androgenic anabolic steroids - review

Volltext

Referenzen

References
1 Spitzer M, Huang G, Basaria S, Travison TG, Bhasin S. Risks and benefits of testosterone therapy in older men. Nat Rev Endocrinol 2013; 9 (07) 414-424 Doi: 10.1038/nrendo.2013.73
2 Orwoll E, Lambert LC, Marshall LM. , et al; Osteoporotic Fractures in Men Study Group. Endogenous testosterone levels, physical performance, and fall risk in older men. Arch Intern Med 2006; 166 (19) 2124-2131 Doi: 10.1001/archinte.166.19.2124
3 Roy TA, Blackman MR, Harman SM, Tobin JD, Schrager M, Metter EJ. Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men. Am J Physiol Endocrinol Metab 2002; 283 (02) E284-E294 Doi: 10.1152/ajpendo.00334.2001
4 Travison TG, Morley JE, Araujo AB, O'Donnell AB, McKinlay JB. The relationship between libido and testosterone levels in aging men. J Clin Endocrinol Metab 2006; 91 (07) 2509-2513 Doi: 10.1210/jc.2005-2508
5 van den Beld AW, de Jong FH, Grobbee DE, Pols HA, Lamberts SW. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab 2000; 85 (09) 3276-3282 Doi: 10.1210/jcem.85.9.6825
6 Ferrando AA, Sheffield-Moore M, Yeckel CW. , et al. Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab 2002; 282 (03) E601-E607 Doi: 10.1152/ajpendo.00362.2001
7 Kenny AM, Prestwood KM, Gruman CA, Marcello KM, Raisz LG. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 2001; 56 (05) M266-M272 Doi: 10.1093/gerona/56.5.M266
8 Krause Neto W, Ciena AP, Anaruma CA, de Souza RR, Gama EF. Effects of exercise on neuromuscular junction components across age: systematic review of animal experimental studies. BMC Res Notes 2015; 8: 713 Doi: 10.1186/s13104-015-1644-4
9 Page ST, Amory JK, Bowman FD. , et al. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 2005; 90 (03) 1502-1510 Doi: 10.1210/jc.2004-1933
10 Sih R, Morley JE, Kaiser FE, Perry III HM, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 1997; 82 (06) 1661-1667 Doi: 10.1210/jcem.82.6.3988
11 Coviello AD, Lakshman K, Mazer NA, Bhasin S. Differences in the apparent metabolic clearance rate of testosterone in young and older men with gonadotropin suppression receiving graded doses of testosterone. J Clin Endocrinol Metab 2006; 91 (11) 4669-4675 Doi: 10.1210/jc.2006-0822
12 Bhasin S, Cunningham GR, Hayes FJ. , et al; Task Force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 95 (06) 2536-2559 Doi: 10.1210/jc.2009-2354
13 Calof OM, Singh AB, Lee ML. , et al. Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci 2005; 60 (11) 1451-1457 Doi: 10.1093/gerona/60.11.1451
14 Xu L, Freeman G, Cowling BJ, Schooling CM. Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med 2013; 11 (01) 108 Doi: 10.1186/1741-7015-11-108
15 Nucci RAB, Teodoro ACS, Krause Neto W. , et al. Effects of testosterone administration on liver structure and function in aging rats. Aging Male 2017; 20 (02) 134-137 Doi: 10.1080/13685538.2017.1284779
16 Tanasov VS, Krause Neto W, Gonçalves L, Maifrino LBM, De Sousa RR, Gama EF. . Use of Anabolic Steroid Altered the Liver Morphology of Rats. Int J Morphol 2014; 32 (03) 756-760 Doi: 10.4067/S0717-95022014000300002
17 Vieira RP, França RF, Damaceno-Rodrigues NR. , et al. Dose-dependent hepatic response to subchronic administration of nandrolone decanoate. Med Sci Sports Exerc 2008; 40 (05) 842-847
18 Nucci RAB, Teodoro ACS. GAMA EF. Liver regeneration and aging: a review. J Morphol 2016; 33 (04) 179-182 Doi: 10.4322/jms.100616
19 Schmucker DL. Age-related changes in liver structure and function: Implications for disease?. Exp Gerontol 2005; 40 (8-9): 650-659 Doi: 10.1016/j.exger.2005.06.009
20 Liberati A, Altman DG, Tetzlaff J. , et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009; 6 (07) e1000100 Doi: 10.1371/journal.pmed.1000100
21 Krause Neto W, Gama EF, Rocha LY. , et al. Effects of testosterone on lean mass gain in elderly men: systematic review with meta-analysis of controlled and randomized studies. Age (Dordr) 2015; 37 (01) 9742
22 Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276 (5309): 60-66
23 Hall J, Jones RD, Jones TH, Channer KS, Peers C. Selective inhibition of L-type Ca2+ channels in A7r5 cells by physiological levels of testosterone. Endocrinology 2006; 147 (06) 2675-2680 Doi: 10.1210/en.2005-1243
24 Gore RM, Mathieu DG, White EM, Ghahremani GG, Panella JS, Rochester D. Passive hepatic congestion: cross-sectional imaging features. AJR Am J Roentgenol 1994; 162 (01) 71-75 Doi: 10.2214/ajr.162.1.8273693
25 Ou QJ, Hermann RE. The role of hepatic veins in liver operations. Surgery 1984; 95 (04) 381-391
26 Simonetto DA, Yang HY, Yin M. , et al. Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces. Hepatology 2015; 61 (02) 648-659
27 Wanless IR, Liu JJ, Butany J. Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis). Hepatology 1995; 21 (05) 1232-1237